Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Austria’s Regulatory Reporting Infrastructure to Move to the Cloud with Nasdaq AxiomSL
-
Medigene and EpimAb Biotherapeutics Enter into a Co-Development Partnership for TCR-Guided T Cell Engagers
-
Municipality Finance issues USD 20 million notes under its MTN programme
-
Quantexa Announces Inaugural Telecoms Product Advisory Board at Mobile World Congress 2025
-
Ipsos: Monthly declaration of shares and voting rights - Janvier 2025
-
Correction: Annual Report 2024
-
Fourth Quarter Report 2024
-
Annual Report 2024
-
INVL Asset Management launches new INVL Partner Strategic Lending Fund which will invest in a fund that lends to the world’s biggest private equity managers
-
RAMSAY SANTE :Ramsay Health Care Limited Financial advisor announcement - 27 February 2025
-
Form 8.3 - Assura PLC - Correction
-
Deutsche Telekom’s T Wholesale and Nokia energize network API market with commercial deal to drive and simplify developer-created applications #MWC 2025
-
Belite Bio Announces Interim Analysis Results from the Pivotal Global Phase 3 DRAGON trial of Tinlarebant in Adolescent Stargardt Disease Subjects
-
SalMar - Settlement of acquisition of shares in AS Knutshaugfisk – issue of new shares
-
IDEX Biometrics interim report for the fourth quarter and preliminary result for 2024
-
Vow ASA: Full year and second half of 2024 results
-
Reminder of an Investor Conference Webinar
-
Subsea 7 S.A. Announces Fourth Quarter and Full Year 2024 Results
-
Key information relating to the proposed cash dividend to be paid by Subsea 7 S.A.
-
Amaroq presents Nalunaq 2024 Exploration Results
-
Form 8.3 - Assura PLC - Correction
-
World cup skier Robin Gillon kicks off Hear My Life ambassador relay with an inspiring two-day event in Park City, Utah
-
NB Private Equity Partners Announces Transaction in Own Shares
-
Significant milestone reached for EG 427 with first patient treated with EG110A, first non-replicative herpes vector based genetic medicine for the treatment of neurogenic bladder
-
GM Statement
-
MANAGERS' AND CLOSELY RELATED PARTIES' TRANSACTIONS WITH DFDS SHARES
-
Pharming Group to report fourth quarter and full year 2024 financial results on March 13
-
Astragalus Coffee Spreads Its Fragrance in Paris：Yangtze River Pharmaceutical Group's Health Products Debut at Paris International Agricultural Show
-
Astragalus Coffee Spreads Its Fragrance in Paris：Yangtze River Pharmaceutical Group's Health Products Debut at Paris International Agricultural Show
-
BW Offshore: Dividend information
-
Azerion publishes Interim Unaudited Financial Results Q4 2024 and Preliminary Unaudited Financial Results Full Year 2024
-
FERRARI PARTICIPATED AS A PURCHASER IN EXOR’S ACCELERATED BOOKBUILD OFFERING
-
Correction: Exor Press Release - ABO Pricing
-
Exor Press Release - ABO Launch
-
BW Offshore: Fourth quarter and full year results 2024
-
Technip Energies Full Year 2024 Financial Results
-
Vallourec Fourth Quarter and Full Year 2024 Results
-
Aalberts N.V.: Aalberts delivers resilient performance in challenging markets
-
Transaction in Own Shares
-
Ageas reports full-year results 2024
-
Bitget Wallet Introduces Smart Authorization Detection to Safeguard Assets
-
Intention to issue bonds
-
Alm. Brand A/S - Annual Report 2024
-
Saudi Arabia’s Ministry of Energy awards prestigious feedstock allocation for joint project between Sipchem and LyondellBasell
-
Syensqo launches the third tranche of its Share Buyback Program
-
CMB.TECH announces Q4 2024 results
-
Syensqo to explore a potential US listing
-
Bigbank AS Results for January 2025
-
PCI Biotech full year 2024 interim results
-
Start of Day Message
